AI-guided treatment for new atrial fibrillation
Part of Heart & circulation clinical trials.
This study is testing if an AI program can help doctors choose better treatments for atrial fibrillation (AF). It is for people who were recently diagnosed with AF and have noticeable symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You need a diagnosis of atrial fibrillation (AF) made in the last 6 months
- You should have at least mild symptoms like palpitations, dizziness, shortness of breath, or feeling faint
- You must not have severe kidney disease (stage 4 or 5) or be on dialysis
- You must not have dementia or other memory/thinking problems
- You should not have a reversible cause of AF (like surgery, infection, or thyroid issues) or be in another AF trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using an artificial intelligence (AI) system to read your electrocardiogram (ECG, a heart rhythm test) can better evaluate your heart's structure and function, helping manage atrial fibrillation (AF). You may qualify if you have AF and need an echocardiogram (ultrasound of the heart).
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
This trial is testing a new approach to care for older adults with atrial fibrillation (an irregular heartbeat) who also have other health conditions. It aims to see if a more integrated, team-based care plan helps improve their overall health and quality of life.
This trial uses an artificial intelligence system to analyze your electrocardiogram (ECG) results and alert your care team if you might be developing atrial fibrillation. It aims to catch this common heart rhythm problem early, so you can get treatment sooner.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
This trial uses an artificial intelligence system (vMap) to find and target abnormal electrical signals outside the pulmonary veins that may be driving atrial fibrillation (AF). The goal is to improve ablation results for people with persistent or recurrent AF.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.